Synthon Pharmaceuticals
FDA Approved Drugs
Synthon Pharmaceuticals
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 32
- Latest Approval Date Sep 25, 2024
- Data Source FDA
- First Approval Date Jan 17, 2001
Company Overview
Company
Synthon Pharmaceuticals
Country
Netherlands
Website
Social Profiles
Company Snapshot
Synthon Pharmaceuticals
PO Box 70716503 GN NijmegenThe Netherlands
Netherlands
www.synthon.com/ communications@synthon.com View on MapFDA Approved Drug Records ( 32 records )
Drug Name
AMLODIPINE BESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2007-09-27
Active Ingredient
AMLODIPINE BESYLATE
Application Number
22026
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2007-09-27
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2007-09-27
Active Ingredient
AMLODIPINE BESYLATE
Application Number
22026
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2007-09-27
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2007-09-27
Active Ingredient
AMLODIPINE BESYLATE
Application Number
22026
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2007-09-27
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2007-06-27
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77080
Product Number
1
Dosage Form
-
Strength
EQ 2.5MG BASE
Approval Date
2007-06-27
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2007-06-27
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77080
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2007-06-27
Regulatory Status
Discontinued
Drug Name
AMLODIPINE BESYLATE
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2007-06-27
Active Ingredient
AMLODIPINE BESYLATE
Application Number
77080
Product Number
3
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2007-06-27
Regulatory Status
Discontinued
Drug Name
ANASTROZOLE
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2010-06-28
Active Ingredient
ANASTROZOLE
Application Number
78322
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2010-06-28
Regulatory Status
Discontinued
Drug Name
BICALUTAMIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2009-07-06
Active Ingredient
BICALUTAMIDE
Application Number
77973
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2009-07-06
Regulatory Status
Discontinued
Drug Name
FLUVOXAMINE MALEATE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2001-01-17
Active Ingredient
FLUVOXAMINE MALEATE
Application Number
75899
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2001-01-17
Regulatory Status
Discontinued
Drug Name
FLUVOXAMINE MALEATE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2001-01-17
Active Ingredient
FLUVOXAMINE MALEATE
Application Number
75899
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2001-01-17
Regulatory Status
Discontinued
Drug Name
FLUVOXAMINE MALEATE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2001-01-17
Active Ingredient
FLUVOXAMINE MALEATE
Application Number
75899
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2001-01-17
Regulatory Status
Discontinued
Drug Name
GLATIRAMER ACETATE
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2024-09-25
Active Ingredient
GLATIRAMER ACETATE
Application Number
203857
Product Number
1
Dosage Form
-
Strength
20MG/ML
Approval Date
2024-09-25
Regulatory Status
RX
Drug Name
GLATIRAMER ACETATE
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2024-09-25
Active Ingredient
GLATIRAMER ACETATE
Application Number
206873
Product Number
1
Dosage Form
-
Strength
40MG/ML
Approval Date
2024-09-25
Regulatory Status
RX
Drug Name
LETROZOLE
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2011-06-03
Active Ingredient
LETROZOLE
Application Number
90196
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2011-06-03
Regulatory Status
Discontinued
Drug Name
LEVOCETIRIZINE DIHYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2010-11-26
Active Ingredient
LEVOCETIRIZINE DIHYDROCHLORIDE
Application Number
90229
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2010-11-26
Regulatory Status
RX
Drug Name
OZANIMOD
Product Number
2
Dosage Form
-
Strength
0.46MG
Approval Date
-
Active Ingredient
OZANIMOD
Application Number
219236
Product Number
2
Dosage Form
-
Strength
0.46MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
OZANIMOD
Product Number
3
Dosage Form
-
Strength
0.23MG
Approval Date
-
Active Ingredient
OZANIMOD
Application Number
219236
Product Number
3
Dosage Form
-
Strength
0.23MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RISPERIDONE
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
2009-10-22
Active Ingredient
RISPERIDONE
Application Number
78187
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
2009-10-22
Regulatory Status
Discontinued
Drug Name
RISPERIDONE
Product Number
2
Dosage Form
-
Strength
0.5MG
Approval Date
2009-10-22
Active Ingredient
RISPERIDONE
Application Number
78187
Product Number
2
Dosage Form
-
Strength
0.5MG
Approval Date
2009-10-22
Regulatory Status
Discontinued
Drug Name
RISPERIDONE
Product Number
3
Dosage Form
-
Strength
1MG
Approval Date
2009-10-22
Active Ingredient
RISPERIDONE
Application Number
78187
Product Number
3
Dosage Form
-
Strength
1MG
Approval Date
2009-10-22
Regulatory Status
Discontinued
Drug Name
RISPERIDONE
Product Number
4
Dosage Form
-
Strength
2MG
Approval Date
2009-10-22
Active Ingredient
RISPERIDONE
Application Number
78187
Product Number
4
Dosage Form
-
Strength
2MG
Approval Date
2009-10-22
Regulatory Status
Discontinued
Drug Name
RISPERIDONE
Product Number
5
Dosage Form
-
Strength
3MG
Approval Date
2009-10-22
Active Ingredient
RISPERIDONE
Application Number
78187
Product Number
5
Dosage Form
-
Strength
3MG
Approval Date
2009-10-22
Regulatory Status
Discontinued
Drug Name
RISPERIDONE
Product Number
6
Dosage Form
-
Strength
4MG
Approval Date
2009-10-22
Active Ingredient
RISPERIDONE
Application Number
78187
Product Number
6
Dosage Form
-
Strength
4MG
Approval Date
2009-10-22
Regulatory Status
Discontinued
Drug Name
SIMVASTATIN
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2007-10-09
Active Ingredient
SIMVASTATIN
Application Number
21961
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2007-10-09
Regulatory Status
Discontinued
Drug Name
SIMVASTATIN
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2007-10-09
Active Ingredient
SIMVASTATIN
Application Number
21961
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2007-10-09
Regulatory Status
Discontinued
Drug Name
SIMVASTATIN
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2007-10-09
Active Ingredient
SIMVASTATIN
Application Number
21961
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2007-10-09
Regulatory Status
Discontinued
Drug Name
SIMVASTATIN
Product Number
4
Dosage Form
-
Strength
80MG
Approval Date
2007-10-09
Active Ingredient
SIMVASTATIN
Application Number
21961
Product Number
4
Dosage Form
-
Strength
80MG
Approval Date
2007-10-09
Regulatory Status
Discontinued
Drug Name
TAMSULOSIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.4MG
Approval Date
2010-04-27
Active Ingredient
TAMSULOSIN HYDROCHLORIDE
Application Number
78801
Product Number
1
Dosage Form
-
Strength
0.4MG
Approval Date
2010-04-27
Regulatory Status
RX
Drug Name
ZOLPIDEM TARTRATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2007-04-23
Active Ingredient
ZOLPIDEM TARTRATE
Application Number
77540
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2007-04-23
Regulatory Status
Discontinued
Drug Name
ZOLPIDEM TARTRATE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2007-04-23
Active Ingredient
ZOLPIDEM TARTRATE
Application Number
77540
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2007-04-23
Regulatory Status
Discontinued
Drug Name
ZOLPIDEM TARTRATE
Product Number
1
Dosage Form
-
Strength
6.25MG
Approval Date
2011-04-12
Active Ingredient
ZOLPIDEM TARTRATE
Application Number
78483
Product Number
1
Dosage Form
-
Strength
6.25MG
Approval Date
2011-04-12
Regulatory Status
Discontinued
Drug Name
ZOLPIDEM TARTRATE
Product Number
2
Dosage Form
-
Strength
12.5MG
Approval Date
2011-06-06
Active Ingredient
ZOLPIDEM TARTRATE
Application Number
78483
Product Number
2
Dosage Form
-
Strength
12.5MG
Approval Date
2011-06-06
Regulatory Status
Discontinued
Drug Status Breakdown
32 total- Discontinued
- RX
- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
AMLODIPINE BESYLATE
Application Number
22026
Product Number
1
Active Ingredient
AMLODIPINE BESYLATE
Dosage Form
-
Strength
EQ 2.5MG BASE
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.